HB5373, titled the Alan Reinstein Ban Asbestos Now Act of 2025, would amend the Toxic Substances Control Act to impose a broad federal ban on commercial asbestos. The bill prohibits the manufacture, processing, use, and distribution in commerce of commercial asbestos and any mixture or article containing it, effective on enactment. It defines “commercial asbestos” to include the asbestiform varieties of chrysotile, crocidolite, amosite, anthophyllite, tremolite, actinolite, richterite, and winchite.
The bill also creates several narrow exceptions and clarifications. It excludes materials where asbestos is present only as an impurity, preserves existing end-use of asbestos-containing products already installed before enactment, and allows distribution solely for disposal in compliance with applicable laws. It further provides a limited transition period for chlor-alkali facilities already operating on enactment day, allowing certain asbestos diaphragm-related uses until January 1, 2030. In addition, the President may grant a one-time national security exemption, subject to findings that no feasible alternative exists, a three-year limit, a possible one-time extension, and Federal Register publication requirements unless publication would harm national security.
The bill would directly change federal chemical safety law by adding a new asbestos-specific subsection to TSCA section 6 and by making clear that the new provisions apply only to chemical substances regulated under TSCA. It also states that the new asbestos ban does not alter other asbestos-related rules, including those under the Federal Food, Drug, and Cosmetic Act for cosmetics. The Administrator would be barred from using TSCA section 22 waiver authority for commercial asbestos.
Because there are no recorded committee transcripts or votes in the provided material, the available sentiment is limited to the bill’s sponsorship and bipartisan introduction by Representatives Bonamici and Bacon. The bill’s title and structure indicate a strong public-health and environmental-safety purpose, with support implied for ending asbestos use while preserving limited operational and national-security carveouts. No formal opposition is documented in the provided record.
The main points of potential contention are the scope of the ban and the exceptions. Industry stakeholders, especially chlor-alkali operators, may focus on the temporary allowance through 2030, while public-health advocates may scrutinize whether any exemption weakens the effectiveness of a full ban. National security exemptions could also be debated because they permit continued asbestos use in limited circumstances if the President finds no feasible alternative.
HB5373 would amend section 6 of the Toxic Substances Control Act, creating a new federal prohibition on commercial asbestos and asbestos-containing mixtures and articles. It would affect manufacturers, processors, users, distributors, and certain facilities that still rely on asbestos, while preserving limited grandfathered end-use, disposal-only distribution, a chlor-alkali transition period, and a narrow national-security exemption. The bill also clarifies that it does not change other asbestos laws or cosmetic-related asbestos requirements, and it removes TSCA waiver authority for commercial asbestos.
The available record suggests generally favorable sentiment toward the bill’s goal of banning asbestos, reflected in its bipartisan introduction and its framing as a public-health measure. Because there are no committee transcripts or votes provided, there is no documented floor or committee debate to quantify support or opposition. The structure of the bill indicates an attempt to balance a strong prohibition with limited exceptions for existing uses and national-security needs.
The likely areas of contention are the exceptions and implementation details. Chlor-alkali facilities may support the temporary transition period but could seek broader relief, while environmental and health advocates may argue that any continued asbestos use prolongs exposure risks. The national-security exemption may also draw scrutiny because it allows the President to authorize asbestos use when no feasible alternative exists, and the bill’s treatment of grandfathered installed products and disposal-only distribution could be debated as either necessary practical carveouts or loopholes.